v3.26.1
Condensed Consolidated Statement of Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2024 $ 312.5 $ 42.9 $ 660.7 $ 285.4 $ (804.1) $ 127.6
Beginning balance, Shares at Dec. 31, 2024   42.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 53.9     51.6   2.3
Other comprehensive income (loss) 38.5       37.8 0.7
Shares repurchased [1] (47.7) $ (0.5) (11.0) (36.2)    
Stock repurchased, Shares [1]   (0.5)        
Dividends to:            
Brink’s common shareholders (10.4)     (10.4)    
Noncontrolling interests (0.4)         (0.4)
Stock options and awards            
Compensation expense 5.7   5.7      
Other share-based benefit transactions (16.5) $ 0.3 (16.7) (0.1)    
Other share-based benefit transactions, shares   0.3        
Acquisitions of noncontrolling interests [2] (6.6)   0.6   (0.2) (7.0)
Ending balance at Mar. 31, 2025 329.0 $ 42.7 639.3 290.3 (766.5) 123.2
Ending balance, Shares at Mar. 31, 2025   42.7        
Beginning balance at Dec. 31, 2024 312.5 $ 42.9 660.7 285.4 (804.1) 127.6
Beginning balance, Shares at Dec. 31, 2024   42.9        
Ending balance at Dec. 31, 2025 407.3 $ 41.1 632.1 270.1 (665.6) 129.6
Ending balance, Shares at Dec. 31, 2025   41.1        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 34.8     32.1   2.7
Other comprehensive income (loss) 0.4       1.4 (1.0)
Shares repurchased [1] (28.6) $ (0.2) (2.3) (26.1)    
Stock repurchased, Shares [1]   (0.2)        
Dividends to:            
Brink’s common shareholders (10.5)     (10.5)    
Noncontrolling interests (0.2)         (0.2)
Stock options and awards            
Compensation expense 7.1   7.1      
Consideration from exercise of stock options 0.2   0.2      
Other share-based benefit transactions (17.4) $ 0.3 (17.7) 0.0    
Other share-based benefit transactions, shares   0.3        
Ending balance at Mar. 31, 2026 $ 393.1 $ 41.2 $ 619.4 $ 265.6 $ (664.2) $ 131.1
Ending balance, Shares at Mar. 31, 2026   41.2        
[1] Amounts do not agree to cash paid to repurchase shares in the condensed consolidated statements of cash flows or Note 11. The difference is due to the timing of the cash settlements for shares repurchased near the balance sheet dates plus the accrual of liabilities to pay excise taxes resulting from share repurchases.
[2] This amount represents the impact of transactions in which we acquired or disposed of noncontrolling ownership interests in certain companies where we had an existing controlling interest prior to and after the related acquisition or disposal transactions.